UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

Diabetes care, 2016-03, Vol.39 (3), p.337-344

2016

Volltextzugriff (PDF)

Preventing type 1 diabetes in childhood

Science (American Association for the Advancement of Science), 2021-07, Vol.373 (6554), p.506-510

2021

Volltextzugriff (PDF)

Precision medicine in type 1 diabetes

Diabetologia, 2022-11, Vol.65 (11), p.1854-1866

2022

Volltextzugriff (PDF)

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10022), p.945-956

2016

Volltextzugriff (PDF)

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Diabetologia, 2019-07, Vol.62 (7), p.1167-1172

2019

Volltextzugriff (PDF)

Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth

Diabetes care, 2022-05, Vol.45 (5), p.1124-1131

2022

Volltextzugriff (PDF)

1251-P: Aß Classification Defines Four Distinct Forms of Diabetes in Children

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

Diabetes (New York, N.Y.), 2022-07, Vol.71 (7), p.1591-1596

2022

Volltextzugriff (PDF)

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

Diabetes care, 2021-08, Vol.44 (8), p.1826-1834

2021

Volltextzugriff (PDF)

1425-P: C-Peptide and Islet Autoantibodies at Diagnosis Predict Long-Term ß-Cell Function and Insulin Dependence in Pediatric Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis

Diabetic medicine, 2024-09, Vol.41 (9), p.e15394-n/a

2024

Volltextzugriff (PDF)

Erratum. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care 2022;45:994–1006

Diabetes care, 2023-11, Vol.46 (11), p.2084-2084

2023

Volltextzugriff (PDF)

Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives

The journal of clinical endocrinology and metabolism, 2024-05

2024

Volltextzugriff (PDF)

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study

Diabetologia, 2024-06

2024

Volltextzugriff (PDF)

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function

Diabetes care, 2020-10, Vol.43 (10), p.2362-2370

2020

Volltextzugriff (PDF)

Investigating hyperkalaemia in adults

BMJ (Online), 2015-10, Vol.351, p.h4762

2015

Volltextzugriff (PDF)

1254-P: Genetic Prediction of C-Peptide Trajectory before Type 1 Diabetes Diagnosis in TrialNet

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

A foundation model for generalizable disease detection from retinal images

Nature (London), 2023-10, Vol.622 (7981), p.156-163

2023

Volltextzugriff (PDF)

The clinical consequences of heterogeneity within and between different diabetes types

Diabetologia, 2020-10, Vol.63 (10), p.2040-2048

2020

Volltextzugriff (PDF)

Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834

Diabetes care, 2022-02, Vol.45 (2), p.e43-e44

2022

Volltextzugriff (PDF)

New insights on the genetics of type 1 diabetes

Current opinion in endocrinology, diabetes, and obesity, 2019-08, Vol.26 (4), p.181

2019

Volltextzugriff (PDF)

216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

1298-P: Independent Associations of GAD65, IA2, and ZnT8 Autoantibody (Ab) Positivity with C-Peptide (CPep) in a Diverse Cohort of Youth with Diabetes (DM)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

27-OR: Residual Beta-Cell Function Associates with Lower Glycaemic Variability and More Time in Range in Individuals with Type 1 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

SpracheNiederländisch

ThemaMale

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

Preventing type 1 diabetes in childhood

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Precision medicine in type 1 diabetes

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth

1251-P: Aß Classification Defines Four Distinct Forms of Diabetes in Children

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

1425-P: C-Peptide and Islet Autoantibodies at Diagnosis Predict Long-Term ß-Cell Function and Insulin Dependence in Pediatric Diabetes

Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis

Erratum. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care 2022;45:994–1006

Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function

Investigating hyperkalaemia in adults

1254-P: Genetic Prediction of C-Peptide Trajectory before Type 1 Diabetes Diagnosis in TrialNet

A foundation model for generalizable disease detection from retinal images

The clinical consequences of heterogeneity within and between different diabetes types

Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834

New insights on the genetics of type 1 diabetes

216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis

1298-P: Independent Associations of GAD65, IA2, and ZnT8 Autoantibody (Ab) Positivity with C-Peptide (CPep) in a Diverse Cohort of Youth with Diabetes (DM)

27-OR: Residual Beta-Cell Function Associates with Lower Glycaemic Variability and More Time in Range in Individuals with Type 1 Diabetes

Aktive Filter

Suchergebnisse filtern